Utah Medical Products Inc Cash Flow Conversion Efficiency
Utah Medical Products Inc cash flow conversion efficiency. Based on the latest financial reports, Utah Medical Products Inc (UTMD) has a cash flow conversion efficiency ratio of 0.026x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.11 Million) by net assets ($120.37 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Utah Medical Products Inc (1989–2025)
Cash flow conversion efficiency of Utah Medical Products Inc from 1989 to 2025. This chart illustrates how Utah Medical Products Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Utah Medical Products Inc (UTMD) share price today for real-time trading data and today's change.
Utah Medical Products Inc Cash Flow Conversion Ratio Explained
Utah Medical Products Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Utah Medical Products Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Utah Medical Products Inc ranked by their cash flow conversion efficiency. Also see market value of Utah Medical Products Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jasuindo Tiga Perkasa Tbk
JK:JTPE
|
-0.046x |
|
Simplex Infrastructures Limited
NSE:SIMPLEXINF
|
0.222x |
|
Smart Parking Ltd
AU:SPZ
|
0.132x |
|
Piedmont Lithium Inc
AU:PLL
|
-0.008x |
|
Atreyu Capital Markets Ltd
TA:ATRY
|
0.267x |
|
Halla Holdings Corp
KO:060980
|
0.018x |
|
BRC Inc.
NYSE:BRCC
|
0.080x |
|
CARGO Therapeutics, Inc. Common Stock
NASDAQ:CRGX
|
-0.326x |
Annual Cash Flow Conversion Efficiency for Utah Medical Products Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Utah Medical Products Inc from 1989 to 2025. Review UTMD FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $119.27 Million | $14.69 Million | 0.123x | -2.47% |
| 2024-12-31 | $117.43 Million | $14.83 Million | 0.126x | -27.27% |
| 2023-12-31 | $128.31 Million | $22.28 Million | 0.174x | -6.18% |
| 2022-12-31 | $114.25 Million | $21.15 Million | 0.185x | -6.48% |
| 2021-12-31 | $107.14 Million | $21.20 Million | 0.198x | +1.05% |
| 2020-12-31 | $102.82 Million | $20.14 Million | 0.196x | +16.08% |
| 2019-12-31 | $101.09 Million | $17.06 Million | 0.169x | -10.81% |
| 2018-12-31 | $88.99 Million | $16.83 Million | 0.189x | -12.60% |
| 2017-12-31 | $78.12 Million | $16.91 Million | 0.216x | +3.16% |
| 2016-12-31 | $69.24 Million | $14.53 Million | 0.210x | +5.88% |
| 2015-12-31 | $69.65 Million | $13.80 Million | 0.198x | -16.86% |
| 2014-12-31 | $64.56 Million | $15.39 Million | 0.238x | +17.31% |
| 2013-12-31 | $60.58 Million | $12.31 Million | 0.203x | -23.64% |
| 2012-12-31 | $50.97 Million | $13.56 Million | 0.266x | -4.58% |
| 2011-12-31 | $40.76 Million | $11.37 Million | 0.279x | +47.25% |
| 2010-12-31 | $37.79 Million | $7.16 Million | 0.189x | -0.46% |
| 2009-12-31 | $37.98 Million | $7.23 Million | 0.190x | -14.69% |
| 2008-12-31 | $34.80 Million | $7.76 Million | 0.223x | +15.74% |
| 2007-12-31 | $38.79 Million | $7.47 Million | 0.193x | -35.88% |
| 2006-12-31 | $36.12 Million | $10.85 Million | 0.301x | +53.06% |
| 2005-12-31 | $32.86 Million | $6.45 Million | 0.196x | -74.15% |
| 2004-12-31 | $36.16 Million | $27.46 Million | 0.759x | +232.86% |
| 2003-12-31 | $36.53 Million | $8.34 Million | 0.228x | -58.56% |
| 2002-12-31 | $15.72 Million | $8.66 Million | 0.551x | +27.53% |
| 2001-12-31 | $18.21 Million | $7.86 Million | 0.432x | -31.88% |
| 2000-12-31 | $12.35 Million | $7.83 Million | 0.634x | +30.84% |
| 1999-12-31 | $18.79 Million | $9.10 Million | 0.484x | +32.57% |
| 1998-12-31 | $26.00 Million | $9.50 Million | 0.365x | +65.15% |
| 1997-12-31 | $22.60 Million | $5.00 Million | 0.221x | -51.80% |
| 1996-12-31 | $24.40 Million | $11.20 Million | 0.459x | +20.75% |
| 1995-12-31 | $29.20 Million | $11.10 Million | 0.380x | +1.08% |
| 1994-12-31 | $23.40 Million | $8.80 Million | 0.376x | +26.03% |
| 1993-12-31 | $24.80 Million | $7.40 Million | 0.298x | +16.09% |
| 1992-12-31 | $24.90 Million | $6.40 Million | 0.257x | +15.99% |
| 1991-12-31 | $17.60 Million | $3.90 Million | 0.222x | -12.13% |
| 1990-12-31 | $11.50 Million | $2.90 Million | 0.252x | -58.95% |
| 1989-12-31 | $7.00 Million | $4.30 Million | 0.614x | -- |
About Utah Medical Products Inc
Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including … Read more